Status:
NOT_YET_RECRUITING
ED Patient's Perceptions and Acceptability Toward a Novel POC HCV Viral Load Testing
Lead Sponsor:
Johns Hopkins University
Collaborating Sponsors:
Cepheid
Conditions:
Hepatitis C
Eligibility:
All Genders
18-100 years
Phase:
NA
Brief Summary
Hepatitis C virus (HCV) infection has become the leading fatal infectious disease in the United States. Approximately 75% of individuals who have been infected with HCV are chronically infected with t...
Detailed Description
Johns Hopkins Emergency Department-Based Rapid HCV Screening and Linkage to Care Program Johns Hopkins Hospital Emergency Department (JHHED) has implemented an ED-based rapid HCV Screening and Linkag...
Eligibility Criteria
Inclusion
- Any Johns Hopkins Emergency Department patient who has HCV antibody positive result but no HCV RNA test result in the chart
- Able to provide informed consent
- 18-100 years
Exclusion
- Patient who has a diagnosis of chronic HCV infection
- Patient with a non-reactive test result of an HCV Ab screening test
- Patient with a chief complaint of sexual assault
- Patients who are otherwise ineligible to consent due to medical condition (e.g., severe illness, altered mental status)
- Any person who has previously enrolled in this study
- Any person less than 18 years of age
- Any person who is incarcerated
- Any woman who is pregnant
- Any person who is transgender
- Any person who is sex worker
- Any person who is refugee
Key Trial Info
Start Date :
November 1 2026
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2027
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT03767231
Start Date
November 1 2026
End Date
November 1 2027
Last Update
November 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Johns Hopkins University
Baltimore, Maryland, United States, 21287